SCHEMBL3396717

SCHEMBL3396717

O=C(C=Cc1ccccn1)c1ccc(Br)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.63
KDM4E B2RXH2 3/20 0.63
HSP90AA1 P07900 2/20 0.63
ALDH1A1 P00352 2/20 0.63
TUBB4A P04350 2/20 0.63
TUBB P07437 2/20 0.63
TUBA3C P0DPH7 2/20 0.63
TUBA1B P68363 2/20 0.63
TUBA4A P68366 2/20 0.63
TUBB4B P68371 2/20 0.63
TUBB3 Q13509 2/20 0.63
TUBB2A Q13885 2/20 0.63
TUBB8 Q3ZCM7 2/20 0.63
TUBA3E Q6PEY2 2/20 0.63
TUBA1A Q71U36 2/20 0.63
TUBA1C Q9BQE3 2/20 0.63
TUBB6 Q9BUF5 2/20 0.63
TUBB2B Q9BVA1 2/20 0.63
TUBB1 Q9H4B7 2/20 0.63
NPSR1 Q6W5P4 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28414923 1.00 MAPT (0.63) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
Hydrochloric Acid SCHEMBL10718091 0.98 MAPT (0.62) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
Hydrochloric Acid SCHEMBL10718088 0.98 MAPT (0.62) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
SCHEMBL15882451 0.92 TUBB4A (0.72) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
SCHEMBL15882450 0.92 TUBB4A (0.72) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
Wr-190433 SCHEMBL6180067 0.86 TUBB4A (0.66) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
Wr-190433 SCHEMBL30880222 0.86 TUBB4A (0.66) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
Wr-190433 SCHEMBL977482 0.86 TUBB4A (0.66) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
Wr-190433 SCHEMBL29870441 0.86 TUBB4A (0.66) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A
SCHEMBL11473136 0.85 TUBB4A (0.65) MAPTKDM4EHSP90AA1ALDH1A1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2246351-B1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2015-05-06 EP disclosed
US-8624228-B2 Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2014-01-07 US disclosed
US-20100308322-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE Hodogaya Chemical Co,. Ltd. (JP) 2010-12-09 US disclosed
EP-2246351-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE Hodogaya Chemical Co., Ltd. (JP) 2010-11-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100308322-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE KCNH3, KCNH2, PRDM9 MAPT 3949/4885KDM4E 1240/4885HSP90AA1 4841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.